Unknown

Dataset Information

Algorithm development and diagnostic accuracy testing for non-invasive foetal RHD genotyping: an Indian experience.


ABSTRACT:

Background

The discovery of the cell-free foetal DNA (cffDNA) circulating in the maternal plasma enabled prediction of foetal RHD thus eliminating the risks associated with invasive procedures. Non-invasive foetal RHD genotyping has now become the standard approach in developed countries for management of alloimmunised women and is also used for targeted antenatal prophylaxis in non-alloimmunised women.

Materials and methods

cffDNA was extracted from the plasma of 217 RhD negative pregnant women at a gestational age of 10-34 weeks. The foetal RHD genotype was determined by real-time polymerase chain reaction (real-time PCR) amplification of exons 4, 5 and 10 in duplicates. After an initial 54 samples, foetal typing was carried out with RHD exons 5 and 10 for the remaining sa

SUBMITTER: Parchure D 

PROVIDER: S-EPMC9068359 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature